This is Infeeds, an online directory for news, stories and ideas. Share your story with us.
In an era where audiences value authenticity and relevance, content partnerships are emerging as one of the most effective ways for platforms and creators to grow sustainably.
Researchers discovered biological markers that appear in blood during early Parkinson's stages, opening a crucial window for diagnosis before irreversible damage.
A mental health leader's raw account of outsourcing his inner life to algorithms, one exhausted midnight conversation at a time.
From wood-chopping influencers to Reddit's cat bongo enthusiasts, even the most seemingly neutral corners of the internet are breaking their silence.
Read latest on Infeeds
Everything you need to know about streaming The Traitors season 4 on Peacock, including episode schedules, subscription options, and who's still in the game.
Scientists discovered two massive superheated rock structures beneath Africa and the Pacific that have been influencing Earth's magnetic field for millions of years.
For e-commerce business owners targeting customers from New York, understanding what to look for in a distribution center is especially important.
Scientists recreated the 'scent of eternity' from ancient Egyptian embalming balms, and museums are now letting visitors smell what death smelled like 3,000 years ago.
Social media image sizes keep changing, and using wrong dimensions hurts your reach. Here's what actually matters for Instagram, X, Facebook, and LinkedIn in 2026.
Silver crashed 16% on Thursday after a brief rebound, exposing how speculative trading has turned the precious metal into something eerily familiar.
OpenAI's CEO called rival Anthropic 'dishonest' and 'authoritarian' after their ads mocked ChatGPT's upcoming ad integration. Someone's feelings got hurt.
Anthropic trolled OpenAI with clever Super Bowl commercials about ads in chatbots. Sam Altman's reaction? A furious essay calling his rival 'authoritarian.'
Tech giants are burning billions on AI models that can barely outperform their predecessors. When does innovation become expensive theater?
